141 related articles for article (PubMed ID: 27605391)
1. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.
Schneider G; Reker D; Chen T; Hauenstein K; Schneider P; Altmann KH
Angew Chem Int Ed Engl; 2016 Sep; 55(40):12408-11. PubMed ID: 27605391
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of (-)-doliculide, structure-activity relationship studies and its binding to F-actin.
Matcha K; Madduri AV; Roy S; Ziegler S; Waldmann H; Hirsch AK; Minnaard AJ
Chembiochem; 2012 Nov; 13(17):2537-48. PubMed ID: 23129522
[TBL] [Abstract][Full Text] [Related]
3. Rapid identification of a protein binding partner for the marine natural product kahalalide F by using reverse chemical proteomics.
Piggott AM; Karuso P
Chembiochem; 2008 Mar; 9(4):524-30. PubMed ID: 18224648
[No Abstract] [Full Text] [Related]
4. Pharmacological characterization of actin-binding (-)-doliculide.
Foerster F; Braig S; Chen T; Altmann KH; Vollmar AM
Bioorg Med Chem; 2014 Sep; 22(18):5117-22. PubMed ID: 24679674
[TBL] [Abstract][Full Text] [Related]
5. Actin-binding doliculide causes premature senescence in p53 wild type cells.
Foerster F; Chen T; Altmann KH; Vollmar AM
Bioorg Med Chem; 2016 Jan; 24(2):123-9. PubMed ID: 26692350
[TBL] [Abstract][Full Text] [Related]
6. Divergent solid-phase synthesis of natural product-inspired bipartite cyclodepsipeptides: total synthesis of seragamide A.
Arndt HD; Rizzo S; Nöcker C; Wakchaure VN; Milroy LG; Bieker V; Calderon A; Tran TT; Brand S; Dehmelt L; Waldmann H
Chemistry; 2015 Mar; 21(14):5311-6. PubMed ID: 25694199
[TBL] [Abstract][Full Text] [Related]
7. De-orphaning the marine natural product (±)-marinopyrrole A by computational target prediction and biochemical validation.
Schneider P; Schneider G
Chem Commun (Camb); 2017 Feb; 53(14):2272-2274. PubMed ID: 28154844
[TBL] [Abstract][Full Text] [Related]
8. Case studies of the synthesis of bioactive cyclodepsipeptide natural products.
Stolze SC; Kaiser M
Molecules; 2013 Jan; 18(2):1337-67. PubMed ID: 23348990
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Late-Stage Modification of (-)-Doliculide Derivatives Using Matteson's Homologation Approach.
Tost M; Kazmaier U
Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667782
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
[TBL] [Abstract][Full Text] [Related]
12. The chromodepsins - chemistry, biology and biosynthesis of a selective Gq inhibitor natural product family.
Hermes C; König GM; Crüsemann M
Nat Prod Rep; 2021 Dec; 38(12):2276-2292. PubMed ID: 33998635
[TBL] [Abstract][Full Text] [Related]
13. A combinatorial target screening strategy for deorphaning macromolecular targets of natural product.
Wei H; Guan YD; Zhang LX; Liu S; Lu AP; Cheng Y; Cao DS
Eur J Med Chem; 2020 Oct; 204():112644. PubMed ID: 32738412
[TBL] [Abstract][Full Text] [Related]
14. From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-cyclodepsipeptides.
Köcher S; Resch S; Kessenbrock T; Schrapp L; Ehrmann M; Kaiser M
Nat Prod Rep; 2020 Feb; 37(2):163-174. PubMed ID: 31451830
[TBL] [Abstract][Full Text] [Related]
15. Cheminformatics in Natural Product-based Drug Discovery.
Chen Y; Kirchmair J
Mol Inform; 2020 Dec; 39(12):e2000171. PubMed ID: 32725781
[TBL] [Abstract][Full Text] [Related]
16. Natural product inspired compound collections: evolutionary principle, chemical synthesis, phenotypic screening, and target identification.
Laraia L; Waldmann H
Drug Discov Today Technol; 2017 Mar; 23():75-82. PubMed ID: 28647090
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.
Fang J; Wu Z; Cai C; Wang Q; Tang Y; Cheng F
J Chem Inf Model; 2017 Nov; 57(11):2657-2671. PubMed ID: 28956927
[TBL] [Abstract][Full Text] [Related]
18. PGE1 and PGE2 modify platelet function through different prostanoid receptors.
Iyú D; Jüttner M; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):9-16. PubMed ID: 21095237
[TBL] [Abstract][Full Text] [Related]
19. Counting on natural products for drug design.
Rodrigues T; Reker D; Schneider P; Schneider G
Nat Chem; 2016 Jun; 8(6):531-41. PubMed ID: 27219696
[TBL] [Abstract][Full Text] [Related]
20. Revealing the macromolecular targets of complex natural products.
Reker D; Perna AM; Rodrigues T; Schneider P; Reutlinger M; Mönch B; Koeberle A; Lamers C; Gabler M; Steinmetz H; Müller R; Schubert-Zsilavecz M; Werz O; Schneider G
Nat Chem; 2014 Dec; 6(12):1072-8. PubMed ID: 25411885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
